Member Info for Timster

hardcore not zoom :)

£32.50 by 4.30 Friday

think you mean profit not zoom??

£25 Friday 4.30

Of absolute ****** posts

The LFT cant come soon enough :)

amazing

If the derampers and indeed uber rampers influence the price. Nothing but doom today and indeed it is drifting down but that seems to be a usual AVCT trend on no news.
but then on Monday pumpers out in force and it rose sharply.

Human nature I suppose stock market works on fear and greed ..... happy days though its coming, we know its coming!

PAH! I posted that the other day

Does seem a bit excessive . But yeah that's just delivery and collection.

Did. He say it's avacta this time? Or almost say it, or pretty much wanted to say it or was he taking notes with an avacta pen, were they wearing avacta lanyards?

It's definately us, 20 quid tomorow on no news

Great post, Q4 we are due some news. We are 3 weeks into Q4

Gone quiet 3 days since last tweet.

@minimal which of Avacta's competitors are selling a lateral flow device that can identify asymptomatic and symptomatic people in a mater of minutes? I know I know we dont have ours yet but sir Al couldn't be any clearer about how good Affimers are in the ELISA and BAMS test, the same ones that are used in the LFT. Exquisitely specific I believe....

when I joined the upside down triangular perpendicular converging lines of my chart it was a picture of Sir Al drinking tea (Yorkshire brew naturally)

noting of any interest to Avacta holders, apart from Saliva is the way forward for testing

https://avacta.com/interim-results-for-the-period-ended-30-june-2020-webinar-presentation/

Ignore the noise and listen, fast forward to lateral flow if that's all you care about 25 mins. (although its worth listening to the BAMS explanation of just how good the Affimers are at detecting COVID-19)

Avacta will not rush through the process to create a substandard test like so many before it.

just popped out for some lunch and I see we've missed the boat again!!

I'm sure these very well researched knowledgeable posters are right. I must remember to sell all my shares when I get the chance....

Tech transfer is the biggest news item we are waiting for (except BAMS validation) it would have to be RNS'd as its price sensitive.
Unless NDA with Gov overrides all stock market rules so the Government can make a grand reveal...

what context was that? is it a response to an article?

just a reminder that we are waiting on an RNS for tech transfer and until that comes we dont have a test available so none of these trials can be us, slide 30:
https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf

• The Affimer based lateral flow test developed with Cytiva is in the process of technology transfer to BBI Solutions.
This process involves scale-up of the manufacturing processes and optimisation of the performance of devices
manufactured with the scaled up processes; the first pilot batch will be 10,000 units.
Clinical validation can only be conducted on devices made using the scaled-up process to satisfy CE regulations.
We expect clinical validation to be completed in Q4 dependent on pilot batch availability. •
• The clinical validation and lay user studies are being designed with Liverpool School of Tropical Medicine. •
• Completion of verification and validation will allow Avacta to self-certify for professional use, and completion of the lay user study, will lead to an audit by AYacWa·V notified body for CE marking for consumer use. •
• When the manufacturing development phase is completed and the pilot batch is available, the timeline to clinical validation, CE marking and product launch will be defined more precisely.

definitely not Avacta

amazing ;) just checked your posts cant see you calling the bottom or anything correctly..